Infinity Pharmaceuticals, Inc. ^INFIQ

Finances

	2022	2021	2020	2019
Revenue	2.593 M ^{39.56 %}	1.858 M ^{8.09 %}	1.719 M ^{-43.62 %}	3.049 M
Net income	-44.369 M ^{1.97 %}	-45.262 M ^{-11.78 %}	-40.492 M ^{13.95 %}	-47.057 M
Income before tax	-44.369 M ^{1.97 %}	-45.262 M ^{-11.78 %}	-40.492 M ^{14.05 %}	-47.111 M
Income before tax ratio	-17.11 ^{29.76 %}	-24.36 ^{-3.42 %}	-23.56 ^{-52.45 %}	-15.45
EBITDA	-43.731 M ^{1.95 %}	-44.602 M ^{-18.74 %}	-37.564 M ^{15.26 %}	-44.329 M
Net income ratio	-17.11 ^{29.76 %}	-24.36 ^{-3.42 %}	-23.56 ^{-52.63 %}	-15.43
Ratio EBITDA	-16.87 ^{29.74 %}	-24.01 ^{-9.85 %}	-21.85 ^{-50.30 %}	-14.54
Gross profit ratio	0.40 ^{0.01 %}	0.40 ^{0.12 %}	0.40 ^{128.40 %}	-1.40
Weighted average shs out dil	89.248 M ^{4.26 %}	85.597 M ^{43.00 %}	59.858 M ^{5.04 %}	56.984 M
Weighted average shs out	89.248 M ^{4.26 %}	85.597 M ^{43.00 %}	59.858 M ^{5.04 %}	56.984 M
EPS diluted	-0.50 ^{5.66 %}	-0.53 ^{22.06 %}	-0.68 ^{18.07 %}	-0.83
Earnings per share	-0.50 ^{5.66 %}	-0.53 ^{22.06 %}	-0.68 ^{18.07 %}	-0.83
Gross profit	1.030 M ^{39.57 %}	738.000 K ^{8.21 %}	682.000 K ^{116.01 %}	-4.259 M
Income tax expense	0.000	0.000	0.000 ^{100.00 %}	-54.000 K
Cost of revenue	1.563 M ^{39.55 %}	1.120 M ^{8.00 %}	1.037 M ^{-85.81 %}	7.308 M
General and administrative expenses	13.463 M ^{-5.02 %}	14.174 M ^{14.14 %}	12.418 M ^{-13.09 %}	14.289 M
Selling and marketing expenses	0.000	0.000	0.000	0.000
Other expenses	0.000	0.000	0.000	0.000
Operating expenses	45.874 M ^{0.12 %}	45.821 M ^{16.95 %}	39.179 M ^{-5.38 %}	41.405 M
Cost and expenses	47.437 M ^{1.06 %}	46.941 M ^{16.72 %}	40.216 M ^{-17.44 %}	48.713 M
Research and development expenses	32.411 M ^{2.41 %}	31.647 M ^{18.26 %}	26.761 M ^{-1.31 %}	27.116 M
Selling general and administrative expenses	13.463 M ^{-5.02 %}	14.174 M ^{14.14 %}	12.418 M ^{-13.09 %}	14.289 M
Interest income	0.000	0.000	0.000	0.000
Interest expense	180.000 K ^{0.00 %}	180.000 K ^{-92.64 %}	2.445 M ^{-4.60 %}	2.563 M
Depreciation and amortization	458.000 K ^{-4.58 %}	480.000 K ^{-0.62 %}	483.000 K ^{120.55 %}	219.000 K
Operating income	-44.844 M ^{0.53 %}	-45.083 M ^{-17.11 %}	-38.497 M ^{15.70 %}	-45.664 M
Operating income ratio	-17.29 ^{28.73 %}	-24.26 ^{-8.35 %}	-22.39 ^{-49.53 %}	-14.98
Total other income expenses net	475.000 K ^{365.36 %}	-179.000 K ^{91.03 %}	-1.995 M ^{-37.87 %}	-1.447 M
	2022	2021	2020	2019

	2022	2021	2020	2019
Net debt	-37.396 M ^{52.84 %}	-79.290 M ^{-1 451.97 %}	-5.109 M ^{74.39 %}	-19.953 M
Total investments	158.000 K ^{0.00 %}	158.000 K ^{-97.22 %}	5.680 M ^{-71.86 %}	20.184 M
Total debt	917.000 K ^{-98.20 %}	51.060 M ^{-2.47 %}	52.353 M ^{2 169.31 %}	2.307 M
Accumulated other comprehensive income loss	0.000	0.000 ^{100.00 %}	-1.000 K ^{-108.33 %}	12.000 K
Retained earnings	-855.952 M ^{-5.47 %}	-811.583 M ^{-5.91 %}	-766.321 M ^{-5.58 %}	-725.829 M
Common stock	89.000 K ^{0.00 %}	89.000 K ^{39.06 %}	64.000 K ^{12.28 %}	57.000 K
Total equity	-19.051 M ^{-188.32 %}	21.571 M ^{193.83 %}	-22.989 M ^{-397.55 %}	7.726 M
Other non current liabilities	37.000 K ^{-86.30 %}	270.000 K ^{-99.04 %}	28.266 M ^{74 284.21 %}	38.000 K
Long term debt	47.537 M ^{-4.24 %}	49.644 M ^{115.89 %}	22.995 M ^{-27.12 %}	31.552 M
Total non current liabilities	47.574 M ^{-4.69 %}	49.914 M ^{-2.63 %}	51.261 M ^{62.27 %}	31.590 M
Other current liabilities	8.630 M ^{1 989.59 %}	413.000 K ^{-50.36 %}	832.000 K ^{-1.89 %}	848.000 K
Deferred revenue	0.000 ^{-100.00 %}	9.151 M ^{55.21 %}	5.896 M ^{-13.90 %}	6.848 M
Short term debt	593.000 K ^{-58.12 %}	1.416 M ^{5.91 %}	1.337 M ^{250.92 %}	381.000 K
Total current liabilities	13.628 M ^{2.47 %}	13.300 M ^{20.39 %}	11.047 M ^{13.91 %}	9.698 M
Total liabilities	61.202 M ^{-3.18 %}	63.214 M ^{1.45 %}	62.308 M ^{50.91 %}	41.288 M
Other non current assets	194.000 K ^{259.26 %}	54.000 K ^{980.00 %}	5.000 K ^{-97.67 %}	215.000 K
Long term investments	158.000 K ^{0.00 %}	158.000 K ^{-4.24 %}	165.000 K ^{-47.62 %}	315.000 K
Intangible assets	0.000	0.000	0.000	0.000
GoodWill	0.000	0.000	0.000	0.000
Goodwill and intangible assets	0.000	0.000	0.000	0.000
Property plant equipment net	1.497 M ^{-35.05 %}	2.305 M ^{-26.33 %}	3.129 M ^{-19.83 %}	3.903 M
Total non current assets	1.849 M ^{-26.54 %}	2.517 M ^{-23.70 %}	3.299 M ^{-25.58 %}	4.433 M
Other current assets	1.989 M ^{28.99 %}	1.542 M ^{-19.35 %}	1.912 M ^{-10.53 %}	2.137 M
Short term investments	0.000	0.000 ^{-100.00 %}	5.515 M ^{-72.68 %}	20.184 M
cash and cash equivalents	38.313 M ^{-52.54 %}	80.726 M ^{182.33 %}	28.593 M ^{28.45 %}	22.260 M
Cash and short term investments	38.313 M ^{-52.54 %}	80.726 M ^{136.68 %}	34.108 M ^{-19.64 %}	42.444 M
Total current assets	40.302 M ^{-51.01 %}	82.268 M ^{128.40 %}	36.020 M ^{-19.20 %}	44.581 M
Inventory	0.000	0.000	0.000	0.000
Net receivables	0.000	0.000	0.000	0.000
Tax assets	0.000	0.000	0.000	0.000
Other assets	0.000	0.000	0.000	0.000
Account payables	4.405 M ^{89.87 %}	2.320 M ^{-22.20 %}	2.982 M ^{83.96 %}	1.621 M
Tax payables	0.000	0.000	0.000	0.000
Deferred revenue non current	0.000	0.000	0.000	0.000
Minority interest	0.000	0.000	0.000	0.000
Capital lease obligations	917.000 K ^{-36.14 %}	1.436 M ^{-25.40 %}	1.925 M ^{-16.56 %}	2.307 M
Preferred stock	0.000	0.000	0.000	0.000
Other total stockholders equity	836.812 M ^{0.45 %}	833.065 M ^{12.08 %}	743.269 M ^{1.33 %}	733.486 M
Deferred tax liabilities non current	0.000	0.000	0.000	0.000
Other liabilities	0.000	0.000	0.000	0.000
Total assets	42.151 M ^{-50.28 %}	84.785 M ^{115.63 %}	39.319 M ^{-19.78 %}	49.014 M
	2022	2021	2020	2019

	2022	2021	2020	2019
Deferred income tax	0.000	0.000	0.000	0.000
Stock based compensation	3.621 M ^{34.36 %}	2.695 M ^{85.10 %}	1.456 M ^{-31.74 %}	2.133 M
Change in working capital	-1.039 M ^{-146.93 %}	2.214 M ^{59.86 %}	1.385 M ^{0.14 %}	1.383 M
Accounts receivables	0.000	0.000	0.000	0.000
Inventory	0.000	0.000	0.000	0.000
Accounts payables	-300.000 K ^{-113.78 %}	2.177 M ^{146.83 %}	882.000 K ^{-43.10 %}	1.550 M
Other working capital	-739.000 K ^{-2 097.30 %}	37.000 K ^{-92.64 %}	503.000 K	0.000
Other non cash items	-1.102 M ^{-47.92 %}	-745.000 K ^{-152.13 %}	1.429 M ^{-20.26 %}	1.792 M
Net cash provided by operating activities	-42.431 M ^{-4.46 %}	-40.618 M ^{-13.65 %}	-35.739 M ^{13.94 %}	-41.530 M
Investments in property plant and equipment	-17.000 K ^{-54.55 %}	-11.000 K ^{74.42 %}	-43.000 K ^{98.15 %}	-2.327 M
Acquisitions net	0.000	0.000	0.000	0.000
Purchases of investments	-16.038 M	0.000 ^{100.00 %}	-43.006 M ^{-2.73 %}	-41.864 M
Sales maturities of investments	16.000 M ^{190.91 %}	5.500 M ^{-90.46 %}	57.680 M ^{80.53 %}	31.950 M
Other investing activites	0.000	0.000	0.000	0.000
Net cash used for investing activites	-55.000 K ^{-101.00 %}	5.489 M ^{-62.48 %}	14.631 M ^{219.52 %}	-12.241 M
Debt repayment	0.000	0.000 ^{-100.00 %}	19.572 M	0.000
Common stock issued	73.000 K ^{-99.92 %}	87.105 M ^{1 006.94 %}	7.869 M ^{6 925.89 %}	112.000 K
Common stock repurchased	0.000	0.000	0.000	0.000
Dividends paid	0.000	0.000	0.000	0.000
Other financing activites	0.000	0.000	0.000 ^{-100.00 %}	27.618 M
Net cash used provided by financing activities	73.000 K ^{-99.92 %}	87.105 M ^{217.43 %}	27.441 M ^{-1.04 %}	27.730 M
Effect of forex changes on cash	0.000	0.000	0.000	0.000
Net change in cash	-42.413 M ^{-181.60 %}	51.976 M ^{720.72 %}	6.333 M ^{124.32 %}	-26.041 M
Cash at beginning of period	80.884 M ^{179.80 %}	28.908 M ^{28.05 %}	22.575 M ^{-53.56 %}	48.616 M
Cash at end of period	38.471 M ^{-52.44 %}	80.884 M ^{179.80 %}	28.908 M ^{28.05 %}	22.575 M
Operating cash flow	-42.431 M ^{-4.46 %}	-40.618 M ^{-13.65 %}	-35.739 M ^{13.94 %}	-41.530 M
Capital expenditure	-17.000 K ^{-54.55 %}	-11.000 K ^{74.42 %}	-43.000 K ^{98.15 %}	-2.327 M
Free CashFlow	-42.448 M ^{-4.48 %}	-40.629 M ^{-13.55 %}	-35.782 M ^{18.41 %}	-43.857 M
	2022	2021	2020	2019

	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Revenue	583.000 K ^{-20.25 %}	731.000 K ^{34.62 %}	543.000 K ^{-23.74 %}	712.000 K
Net income	-9.956 M ^{9.86 %}	-11.045 M ^{-19.66 %}	-9.230 M ^{13.88 %}	-10.717 M
Income before tax	-9.956 M ^{9.86 %}	-11.045 M ^{-19.66 %}	-9.230 M ^{13.88 %}	-10.717 M
Income before tax ratio	-17.08 ^{-13.02 %}	-15.11 ^{11.11 %}	-17.00 ^{-12.93 %}	-15.05
EBITDA	-9.805 M ^{10.00 %}	-10.895 M ^{-20.00 %}	-9.079 M ^{14.03 %}	-10.561 M
Net income ratio	-17.08 ^{-13.02 %}	-15.11 ^{11.11 %}	-17.00 ^{-12.93 %}	-15.05
Ratio EBITDA	-16.82 ^{-12.84 %}	-14.90 ^{10.86 %}	-16.72 ^{-12.72 %}	-14.83
Gross profit ratio	0.40 ^{-0.12 %}	0.40 ^{-0.27 %}	0.40 ^{64.67 %}	0.24
Weighted average shs out dil	89.885 M ^{0.53 %}	89.413 M ^{0.03 %}	89.387 M ^{-0.01 %}	89.392 M
Weighted average shs out	89.885 M ^{0.53 %}	89.413 M ^{0.03 %}	89.387 M ^{-0.01 %}	89.392 M
EPS diluted	-0.11 ^{8.33 %}	-0.12 ^{-20.00 %}	-0.10 ^{16.67 %}	-0.12
Earnings per share	-0.11 ^{8.33 %}	-0.12 ^{-20.00 %}	-0.10 ^{16.67 %}	-0.12
Gross profit	231.000 K ^{-20.34 %}	290.000 K ^{34.26 %}	216.000 K ^{25.58 %}	172.000 K
Income tax expense	0.000 ^{-100.00 %}	45.000 K ^{0.00 %}	45.000 K	0.000
Cost of revenue	352.000 K ^{-20.18 %}	441.000 K ^{34.86 %}	327.000 K ^{-39.44 %}	540.000 K
General and administrative expenses	3.754 M ^{-36.84 %}	5.944 M ^{112.97 %}	2.791 M	0.000
Selling and marketing expenses	0.000	0.000	0.000	0.000
Other expenses	0.000	0.000	0.000	0.000
Operating expenses	10.351 M ^{-12.26 %}	11.797 M ^{20.95 %}	9.754 M ^{-11.75 %}	11.053 M
Cost and expenses	10.703 M ^{-12.54 %}	12.238 M ^{21.40 %}	10.081 M ^{-13.04 %}	11.593 M
Research and development expenses	6.597 M ^{12.71 %}	5.853 M ^{-15.94 %}	6.963 M ^{-7.80 %}	7.552 M
Selling general and administrative expenses	3.754 M ^{-36.84 %}	5.944 M ^{112.97 %}	2.791 M ^{-20.28 %}	3.501 M
Interest income	0.000	0.000	0.000 ^{-100.00 %}	209.000 K
Interest expense	45.000 K ^{0.00 %}	45.000 K ^{0.00 %}	45.000 K ^{0.00 %}	45.000 K
Depreciation and amortization	106.000 K ^{0.95 %}	105.000 K ^{-0.94 %}	106.000 K ^{-4.50 %}	111.000 K
Operating income	-10.120 M ^{12.05 %}	-11.507 M ^{-20.64 %}	-9.538 M ^{12.34 %}	-10.881 M
Operating income ratio	-17.36 ^{-10.27 %}	-15.74 ^{10.38 %}	-17.57 ^{-14.94 %}	-15.28
Total other income expenses net	164.000 K ^{-64.50 %}	462.000 K ^{50.00 %}	308.000 K ^{87.80 %}	164.000 K
	2023-06-30	2023-03-31	2022-12-31	2022-09-30

	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Net debt	-17.113 M ^{31.44 %}	-24.960 M ^{33.25 %}	-37.396 M ^{-1 568.81 %}	2.546 M
Total investments	158.000 K ^{0.00 %}	158.000 K ^{0.00 %}	158.000 K ^{0.00 %}	158.000 K
Total debt	633.000 K ^{-18.53 %}	777.000 K ^{-15.27 %}	917.000 K ^{-98.16 %}	49.728 M
Accumulated other comprehensive income loss	0.000	0.000	0.000	0.000
Retained earnings	-876.953 M ^{-1.15 %}	-866.997 M ^{-1.29 %}	-855.952 M ^{-1.09 %}	-846.722 M
Common stock	90.000 K ^{1.12 %}	89.000 K ^{0.00 %}	89.000 K ^{0.00 %}	89.000 K
Total equity	-37.406 M ^{-32.07 %}	-28.322 M ^{-48.66 %}	-19.051 M ^{-75.20 %}	-10.874 M
Other non current liabilities	0.000 ^{-100.00 %}	46.820 M ^{-0.91 %}	47.250 M ^{147 556.25 %}	32.000 K
Long term debt	0.000 ^{-100.00 %}	164.000 K ^{-49.38 %}	324.000 K ^{-99.33 %}	48.233 M
Total non current liabilities	46.574 M ^{-0.87 %}	46.984 M ^{-1.24 %}	47.574 M ^{-1.43 %}	48.265 M
Other current liabilities	9.929 M ^{13.59 %}	8.741 M ^{1.29 %}	8.630 M ^{-26.08 %}	11.674 M
Deferred revenue	0.000 ^{-100.00 %}	6.942 M ^{2.74 %}	6.757 M	0.000
Short term debt	633.000 K ^{3.26 %}	613.000 K ^{3.37 %}	593.000 K ^{3.31 %}	574.000 K
Total current liabilities	12.064 M ^{6.87 %}	11.289 M ^{-17.16 %}	13.628 M ^{-4.03 %}	14.200 M
Total liabilities	58.638 M ^{0.63 %}	58.273 M ^{-4.79 %}	61.202 M ^{-2.02 %}	62.465 M
Other non current assets	84.000 K ^{-39.13 %}	138.000 K ^{-28.87 %}	194.000 K ^{-49.48 %}	384.000 K
Long term investments	158.000 K ^{0.00 %}	158.000 K ^{0.00 %}	158.000 K ^{0.00 %}	158.000 K
Intangible assets	0.000	0.000	0.000	0.000
GoodWill	0.000	0.000	0.000	0.000
Goodwill and intangible assets	0.000	0.000	0.000	0.000
Property plant equipment net	1.082 M ^{-16.25 %}	1.292 M ^{-13.69 %}	1.497 M ^{-11.89 %}	1.699 M
Total non current assets	1.324 M ^{-16.62 %}	1.588 M ^{-14.12 %}	1.849 M ^{-17.49 %}	2.241 M
Other current assets	2.162 M ^{-17.67 %}	2.626 M ^{32.03 %}	1.989 M ^{-8.26 %}	2.168 M
Short term investments	0.000	0.000	0.000	0.000
cash and cash equivalents	17.746 M ^{-31.05 %}	25.737 M ^{-32.82 %}	38.313 M ^{-18.80 %}	47.182 M
Cash and short term investments	17.746 M ^{-31.05 %}	25.737 M ^{-32.82 %}	38.313 M ^{-18.80 %}	47.182 M
Total current assets	19.908 M ^{-29.81 %}	28.363 M ^{-29.62 %}	40.302 M ^{-18.33 %}	49.350 M
Inventory	0.000	0.000	0.000	0.000
Net receivables	0.000	0.000	0.000	0.000
Tax assets	0.000	0.000	0.000	0.000
Other assets	0.000	0.000	0.000	0.000
Account payables	1.502 M ^{-22.38 %}	1.935 M ^{-56.07 %}	4.405 M ^{125.67 %}	1.952 M
Tax payables	0.000	0.000	0.000	0.000
Deferred revenue non current	0.000	0.000	0.000	0.000
Minority interest	0.000	0.000	0.000	0.000
Capital lease obligations	633.000 K ^{-18.53 %}	777.000 K ^{-15.27 %}	917.000 K ^{-13.00 %}	1.054 M
Preferred stock	0.000	0.000	0.000	0.000
Other total stockholders equity	839.457 M ^{0.10 %}	838.586 M ^{0.21 %}	836.812 M ^{0.13 %}	835.759 M
Deferred tax liabilities non current	0.000	0.000	0.000	0.000
Other liabilities	0.000	0.000	0.000	0.000
Total assets	21.232 M ^{-29.11 %}	29.951 M ^{-28.94 %}	42.151 M ^{-18.30 %}	51.591 M
	2023-06-30	2023-03-31	2022-12-31	2022-09-30

	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Deferred income tax	0.000	0.000	0.000	0.000
Stock based compensation	856.000 K ^{-51.75 %}	1.774 M ^{73.58 %}	1.022 M	0.000
Change in working capital	1.250 M ^{143.89 %}	-2.848 M ^{-413.15 %}	-555.000 K ^{-193.28 %}	595.000 K
Accounts receivables	0.000	0.000	0.000	0.000
Inventory	0.000	0.000	0.000	0.000
Accounts payables	772.000 K ^{134.67 %}	-2.227 M ^{-152.21 %}	-883.000 K ^{-2 575.76 %}	-33.000 K
Other working capital	478.000 K ^{176.97 %}	-621.000 K ^{-289.33 %}	328.000 K ^{-47.77 %}	628.000 K
Other non cash items	-263.000 K ^{53.20 %}	-562.000 K ^{-131.28 %}	-243.000 K ^{-128.09 %}	865.000 K
Net cash provided by operating activities	-8.007 M ^{36.33 %}	-12.576 M ^{-41.30 %}	-8.900 M ^{5.33 %}	-9.401 M
Investments in property plant and equipment	0.000	0.000	0.000	0.000
Acquisitions net	0.000	0.000	0.000	0.000
Purchases of investments	0.000	0.000	0.000 ^{100.00 %}	-19.000 K
Sales maturities of investments	0.000	0.000	0.000 ^{-100.00 %}	10.750 M
Other investing activites	0.000	0.000	0.000	0.000
Net cash used for investing activites	0.000	0.000	0.000 ^{-100.00 %}	10.731 M
Debt repayment	0.000	0.000	0.000	0.000
Common stock issued	16.000 K	0.000 ^{-100.00 %}	31.000 K ^{121.43 %}	14.000 K
Common stock repurchased	0.000	0.000	0.000	0.000
Dividends paid	0.000	0.000	0.000	0.000
Other financing activites	16.000 K	0.000	0.000	0.000
Net cash used provided by financing activities	16.000 K	0.000 ^{-100.00 %}	31.000 K ^{121.43 %}	14.000 K
Effect of forex changes on cash	0.000	0.000	0.000	0.000
Net change in cash	-7.991 M ^{36.46 %}	-12.576 M ^{-41.80 %}	-8.869 M ^{-759.90 %}	1.344 M
Cash at beginning of period	25.895 M ^{-32.69 %}	38.471 M ^{-18.73 %}	47.340 M ^{3.28 %}	45.838 M
Cash at end of period	17.904 M ^{-30.86 %}	25.895 M ^{-32.69 %}	38.471 M ^{-18.46 %}	47.182 M
Operating cash flow	-8.007 M ^{36.33 %}	-12.576 M ^{-41.30 %}	-8.900 M ^{5.33 %}	-9.401 M
Capital expenditure	0.000	0.000	0.000	0.000
Free CashFlow	-8.007 M ^{36.33 %}	-12.576 M ^{-41.30 %}	-8.900 M ^{5.33 %}	-9.401 M
	2023	2023	2022	2022

Date	Form 10K
2022	https://www.sec.gov/Archives/edgar/data/1113148/000111314823000003/infi-20221231.htm
2021	https://www.sec.gov/Archives/edgar/data/1113148/000111314822000007/infi-20211231.htm
2020	https://www.sec.gov/Archives/edgar/data/1113148/000111314821000007/infi-20201231.htm
2019	https://www.sec.gov/Archives/edgar/data/1113148/000111314820000004/infi-1231201910xk.htm

Infinity Pharmaceuticals, Inc. INFIQ

Finances

Infinity Pharmaceuticals, Inc. ^INFIQ